Additionally, it enhances cerebral metastases within non-small cell lung cancer cases by triggering epithelial-mesenchymal transition (EMT) [28] CADM2 suppresses glioma growth, migration, and invasion [29]. This evidence concerns the gene CADM2 and non-small cell lung carcinoma.